Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

Outcomes for children with high-grade gliomas (HGG) remain dismal despite aggressive treatment strategies. The use of targeted therapy for BRAF(V600E) mutated malignancies including HGG is being explored as a potentially well tolerated and effective therapeutic option. The results of adult melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Toll, Stephanie A., Tran, Hung N., Cotter, Jennifer, Judkins, Alexander R., Tamrazi, Benita, Biegel, Jaclyn A., Dhall, Girish, Robison, Nathan J., Waters, Kaaren, Patel, Palak, Cooper, Robert, Margol, Ashley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355184/
https://www.ncbi.nlm.nih.gov/pubmed/30728904
http://dx.doi.org/10.18632/oncotarget.26560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355184/
https://www.ncbi.nlm.nih.gov/pubmed/30728904
http://dx.doi.org/10.18632/oncotarget.26560

Ejemplares similares